Delayed multiple sclerosis diagnosis underscores need for urgent research and awareness boost, report find

FHS
May 30, 2024
2:06 am

A new report from MS Australia reveals that the average time to diagnose multiple sclerosis is nearly four years, highlighting the urgent need for increased research investment and enhanced awareness.

The role of phytochemicals in combating metabolic diseases

This editorial reviews the impact of phytochemicals on metabolic diseases, emphasizing their potential in reducing inflammation and improving health outcomes.

December 19, 2024

How Physician Mortality Stacks Up Against the General Population

Cross-sectional data showed that physicians in the U.S. had lower mortality rates than the general population. However, this applied only to men and not women

February 27, 2025

Resilience partners with Saudi-based Lifera to build biomanufacturing site

Lifera, the Saudi Arabian-based contract manufacturer with backing from the nation’s Public Investment Fund, has partnered with manufacturer Resilience to establish a production site. Resilience

August 29, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.